scholarly journals Cilioretinal Artery Occlusion Combined with Central Retinal Vein Occlusion: What Is the Best Imaging Modality for the Follow-Up?

2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Mahmut Kaya ◽  
Taylan Ozturk ◽  
Ziya Ayhan ◽  
Nilufer Kocak ◽  
Suleyman Kaynak
Keyword(s):  
Optical Coherence Tomography ◽  
Artery Occlusion ◽  
Fundus Photography ◽  
Oct Angiography ◽  
Optical Coherence ◽  
Cilioretinal Artery Occlusion ◽  
Cilioretinal Artery ◽  
Central Retinal Vein ◽  
Sd Oct

We report retinal structural changes of a 37-year-old man diagnosed with the concomitant occlusion of cilioretinal artery and central retinal vein. Comprehensive ophthalmological evaluation was performed, followed by spectral-domain optical coherence tomography (SD-OCT, Heidelberg), optical coherence tomography angiography (OCT angiography, Optovue Inc., Fremont, California, USA), fluorescein angiography, and color fundus photography. The use of OCT angiography and en face SD-OCT imaging as an adjunct test to map out correlative paracentral scotomas during follow-up allowed us to evaluate cilioretinal artery occlusion in the best way due to obtaining satisfactory images of the normal retinal vascular networks and areas of nonperfusion and congestion at various retinal levels.

scholarly journals Varicella Retinal Vasculopathy: Unilateral Cilioretinal Artery Occlusion Despite Acyclovir Therapy Caught Using Optical Coherence Tomography-Angiography (OCTA)

2019 ◽  
Vol 2019 ◽  
pp. 1-3
Author(s):  
Anadi Khatri ◽  
Satish Timalsena ◽  
Sudhir Gautam ◽  
Muna Kharel
Keyword(s):  
Optical Coherence Tomography ◽  
Optic Neuritis ◽  
Visual Loss ◽  
Optical Coherence Tomography Angiography ◽  
Artery Occlusion ◽  
Oct Angiography ◽  
Varicella Zoster ◽  
Cilioretinal Artery Occlusion ◽  
Cilioretinal Artery ◽  
Acyclovir Therapy

Varicella zoster is known to be associated with vaso-occlusive pathologies, vasculitis, or optic neuritis, leading to profound visual loss. We report a case where a 13-year-old boy who initially presented to us with on and off diminution of vision in his right eye since 3 days and had normal ocular and OCT angiography findings followed up in 5 days with sudden painless diminution of vision in the same eye since one day this time revealing a pale macular region with rest of the retina being normal. Repeated OCT angiography showed loss of the capillary network around the perifoveal region suggesting cilioretinal artery occlusion.

scholarly journals Optical Coherence Tomography Angiography of Nonarteritic Cilioretinal Artery Occlusion Alone

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Toyo Ikebukuro ◽  
Tsutomu Igarashi ◽  
Shuhei Kameya ◽  
Takeshi Arima ◽  
Tomoyuki Kunishige ◽  
...  
Keyword(s):  
Optical Coherence Tomography ◽  
Rare Disease ◽  
Optical Coherence Tomography Angiography ◽  
Artery Occlusion ◽  
Optical Coherence ◽  
Retinal Circulation ◽  
Cilioretinal Artery Occlusion ◽  
Cilioretinal Artery

Cilioretinal artery occlusion (CLRAO) is a rare disease. Here, we report the case of a 70-year-old man with nonarteritic cilioretinal artery occlusion alone. The patient was allergic to fluorescein. Therefore, we followed the retinal circulation with optical coherence tomography angiography (OCTA). OCTA at 40 days postonset showed partial improvement in the retinal circulation.

Combined Central Retinal Vein and Cilioretinal Artery Occlusion in the Setting of Intravenous Immunoglobulin Administration

2021 ◽  
pp. 247412642199860
Author(s):  
Jonathan Cin-Bon Tsui ◽  
Gordon Scott Crabtree
Keyword(s):  
Intravenous Immunoglobulin ◽  
Vascular Occlusion ◽  
Artery Occlusion ◽  
Necrotizing Autoimmune Myopathy ◽  
Cilioretinal Artery Occlusion ◽  
Cilioretinal Artery ◽  
Optical Coherence Tomography Imaging ◽  
Autoimmune Myopathy ◽  
Central Retinal Vein ◽  
Ivig Administration

Purpose: This work reports a case of combined vascular occlusion in the setting of intravenous immunoglobulin (IVIg) administration. Methods: The authors describe a case of combined central retinal vein and cilioretinal artery that occurred in the setting of IVIg administration. Results: A 52-year-old White man presented with a unilateral subjective scotoma that began during IVIg administered for the treatment of statin-induced necrotizing autoimmune myopathy. Examination and optical coherence tomography imaging revealed a combined nonischemic central retinal vein and cilioretinal artery occlusion. Conclusions: To the authors’ review and knowledge, this is the first reported case of combined central retinal vein and cilioretinal artery occlusion occurring in the setting of IVIg administration. This rare adverse effect is an entity to be considered in patients who are treated with IVIg.

Cilioretinal Artery Occlusion in Young Adults with Central Retinal Vein Occlusion

Ophthalmology ◽  
1991 ◽  
Vol 98 (5) ◽  
pp. 594-601 ◽  
Author(s):  
Howard Schatz ◽  
Andrew C.O. Fong ◽  
H. Richard McDonald ◽  
Robert N. Johnson ◽  
Leonard Joffe ◽  
...  
Keyword(s):  
Young Adults ◽  
Retinal Vein Occlusion ◽  
Central Retinal Vein Occlusion ◽  
Artery Occlusion ◽  
Vein Occlusion ◽  
Cilioretinal Artery Occlusion ◽  
Cilioretinal Artery ◽  
Central Retinal Vein

scholarly journals Retinal Vascular Changes in Radiation Maculopathy after Intravitreal Ranibizumab by Optical Coherence Tomography Angiography

2020 ◽  
Vol 9 (6) ◽  
pp. 1618 ◽  
Author(s):  
Gilda Cennamo ◽  
Daniela Montorio ◽  
Roberta Bernardo ◽  
Antonio Farella ◽  
Raffaele Liuzzi ◽  
...  
Keyword(s):  
Optical Coherence Tomography ◽  
Choroidal Melanoma ◽  
Predictive Biomarkers ◽  
Foveal Avascular Zone ◽  
Functional Improvement ◽  
Optical Coherence ◽  
Foveal Thickness ◽  
Capillary Plexus ◽  
Sd Oct

In this prospective study, we investigated the structural and vascular retinal changes at baseline and after Ranibizumab injections at the last follow up to one year in patients affected by Radiation Maculopathy (RM) after plaque brachytheraphy in choroidal melanoma, using Spectral Domain Optical Coherence Tomography (SD-OCT) and OCT Angiography (OCTA). A total of 40 eyes with RM of 40 patients (18 females, 22 males, mean age 51.9 ± 11 years) that underwent ruthenium-106 plaque brachytherapy were included. All patients received one monthly intravitreal injection of Ranibizumab (Pro Re Nata regimen). We analyzed the Foveal Avascular Zone (FAZ) area, the retinal vessel density (VD) of the superficial capillary plexus (SCP) and of the deep capillary plexus (DCP), using OCTA, and we detected the Central Foveal Thickness (CFT) by SD-OCT at baseline and after treatment. At the last follow up, we found a significant improvement of the CFT (p < 0.001) while OCTA parameters revealed no change in VD of the SCP (p = 0.402), DCP (p = 0.282), and FAZ area (p = 0.255), resulting in a stabilization of the visual acuity (p = 0.210) respect to baseline. The absence of functional improvement, despite the anatomical recovery of the macula, could be due to the absence of improvement in FAZ area and in retinal VD after treatment. OCTA parameters could represent predictive biomarkers to anti-vascular endothelial growth factor (anti-VEGF) intravitreal response and to help to better understand the physiopathological mechanisms of the RM.

Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus

Lupus ◽  
2019 ◽  
Vol 28 (4) ◽  
pp. 555-559 ◽  
Author(s):  
D Martín-Iglesias ◽  
J Artaraz ◽  
A Fonollosa ◽  
A Ugarte ◽  
A Arteagabeitia ◽  
...  
Keyword(s):  
Risk Factors ◽  
Optical Coherence Tomography ◽  
Lupus Erythematosus ◽  
Pigment Epithelium ◽  
Retinal Pigment ◽  
Optical Coherence ◽  
The Mean ◽  
Sd Oct

Objective The objective of this report is to analyse retinal changes over a five-year period, assessed by spectral domain-optical coherence tomography (SD-OCT), in patients from the Lupus-Cruces cohort treated with hydroxychloroquine (HCQ). Methods SD-OCT screening was performed annually between 2012 and 2017. Average macular thickness (AMT), ganglion cell layer thickness (GCLT) and qualitative data of retinal pigment epithelium (RPE) and external retina (ExtR) were collected prospectively. We compared data from 2012 (first) and 2017 (second) SD-OCT. Results We studied 110 patients and 195 eyes. No cases of HCQ toxicity were detected. At the time of the second SD-OCT, 99% patients had taken a daily dose of HCQ ≤5 mg/kg/day. The median time on HCQ was 133 months. The mean AMT and GCLT were significantly lower in both eyes at the second SD-OCT; however, all the differences were clinically insignificant at less than 1%. Qualitative analysis of RPE and ExtR showed no significant changes. Similar results were found among patients with risk factors for retinopathy. The comparison of patients with and without risk factors showed no differences. Conclusions This study shows clinically irrelevant retinal changes in an SLE cohort on HCQ treatment over a five-year follow-up. Our findings support the safety of long-term HCQ at doses ≤5 mg/kg/day.

Sign in / Sign up

Export Citation Format

Share Document